transcription/replication inhibitors (Apath)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nametranscription/replication inhibitors (Apath)
Drug Alias NameRSV inhibitors (Apath)transcription/replication inhibitors (Apath)AP-28687AP-R065AP-80734
ClassificationSmall molecules
Mechanisms of ActionTranscription factors inhibitorsVirus replication inhibitors
TargetsTranscription factors
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApath LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApath LLC
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A